Impact of GLP-1 Receptor Agonists on Immune Function and Vaccine Response
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), like semaglutide, are widely used for managing diabetes and weight loss. However, their extended use raises concerns about their impact on immune responses, particularly vaccine efficacy. Unlike natural GLP-1, GLP-1RAs have longer half-lives and are administered at higher concentrations, potentially affecting immune cells beyond the pancreas.
Impact of Ethnicity and Socioeconomic Status on Diabetic Nephropathy and Retinopathy
Authors of this systematic review and meta-analysis examined the prevalence and progression of diabetic nephropathy (DN) and diabetic retinopathy (DR) in individuals with type 2 diabetes mellitus, focusing on how ethnicity and socioeconomic status (SES) may contribute to variations in these outcomes.
Study Finds No Increased Thyroid Cancer Risk With GLP-1 Receptor Agonists in Type 2 Diabetes
A recent study found no significant difference in the risk of thyroid cancer between adults with type 2 diabetes using glucagon-like peptide-1 (GLP-1) receptor agonists and those using dipeptidyl peptidase 4 (DPP4) inhibitors.
Black Tea With Inulin and Dextrin Reduces Post-Meal Glucose Spikes in T2DM
In this randomized, double-blind, placebo-controlled crossover trial, researchers evaluated the effect of black tea drinks with inulin and dextrin (BTID) on postprandial glucose levels in individuals with type 2 diabetes mellitus (T2DM).
Low-Carb Mediterranean and Plant-Based Diets Show Promise for T2D Remission
A recent evaluated the effectiveness of food-based dietary approaches in achieving remission for individuals with type 2 diabetes (T2D). A systematic search of Medline, EMBASE, and Web of Science was conducted to identify longitudinal studies, which were then assessed for quality.
FIND Trial: No Link Between Vitamin D3 and Type 2 Diabetes Risk in Older Adults
The Finnish Vitamin D Trial (FIND) aimed to evaluate the impact of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults.
Managing Type 2 Diabetes: Personalized Dietary Strategies for Long-Term Outcomes and Quality of Life
Type 2 diabetes mellitus (T2DM) is a chronic, highly prevalent disease linked to aging, sedentary lifestyles, and poor dietary habits, particularly obesity. Obesity contributes significantly to T2DM and other conditions like hypertension and cardiovascular disease.
Umbrella Review Finds CGM Improves Glycemic Control in T2D, but Patient Outcomes Inconclusive
A recent umbrella review evaluated the effectiveness of continuous glucose monitoring (CGM) in patients with type 2 diabetes (T2D) compared to self-monitoring blood glucose or usual care.
Expanding CGM Use in Diabetes: Standardized Metrics, Personalized Goals, and A1C Complementation
The adoption of continuous glucose monitoring (CGM) is growing among both type 1 and type 2 diabetes populations, but its clinical use remains low.
Updated Hypoglycemia Guidelines: Key Recommendations on CGM, Insulin, Education, and Prevention
Hypoglycemia is a common concern for people with diabetes, especially those using insulin and sulfonylureas, as these medications increase the risk.
